These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24135425)

  • 1. Clinical application of high-throughput genomic technologies for treatment selection in breast cancer.
    Hansen AR; Bedard PL
    Breast Cancer Res; 2013; 15(5):R97. PubMed ID: 24135425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial experience with genomic profiling of heavily pretreated breast cancers.
    Staren ED; Braun D; Tan B; Gupta D; Kim S; Kramer K; Markman M
    Ann Surg Oncol; 2014 Oct; 21(10):3216-22. PubMed ID: 25047475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Evolution as the New Frontier of Precision Medicine.
    Curigliano G
    Handb Exp Pharmacol; 2018; 249():289-297. PubMed ID: 30406442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Profiling and Liquid Biopsies for Breast Cancer.
    Marcinak CT; Murtaza M; Wilke LG
    Surg Clin North Am; 2023 Feb; 103(1):49-61. PubMed ID: 36410353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What to expect from high throughput genomics in metastatic breast cancers?
    Onesti CE; Vicier C; André F
    Breast; 2015 Nov; 24 Suppl 2():S19-22. PubMed ID: 26238439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive genomic sequencing and the molecular profiles of clinically advanced breast cancer.
    Ross JS; Gay LM
    Pathology; 2017 Feb; 49(2):120-132. PubMed ID: 28034454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling of breast cancers.
    Curtis C
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):34-9. PubMed ID: 25502431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cancer Genome Atlas: clinical applications for breast cancer.
    Ma CX; Ellis MJ
    Oncology (Williston Park); 2013 Dec; 27(12):1263-9, 1274-9. PubMed ID: 24624545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-Generation Sequencing for Advanced Breast Cancer: What the Way to Go?
    Trapani D; Crimini E; Sandoval J; Curigliano G
    Cancer Treat Res; 2023; 188():343-351. PubMed ID: 38175352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Testing in Breast Cancer.
    Litton JK; Burstein HJ; Turner NC
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e1-e7. PubMed ID: 31099622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance of genomic alterations between primary and recurrent breast cancer.
    Meric-Bernstam F; Frampton GM; Ferrer-Lozano J; Yelensky R; Pérez-Fidalgo JA; Wang Y; Palmer GA; Ross JS; Miller VA; Su X; Eroles P; Barrera JA; Burgues O; Lluch AM; Zheng X; Sahin A; Stephens PJ; Mills GB; Cronin MT; Gonzalez-Angulo AM
    Mol Cancer Ther; 2014 May; 13(5):1382-9. PubMed ID: 24608573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent and pathological gene fusions in breast cancer: current advances in genomic discovery and clinical implications.
    Veeraraghavan J; Ma J; Hu Y; Wang XS
    Breast Cancer Res Treat; 2016 Jul; 158(2):219-32. PubMed ID: 27372070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
    Mack SC; Northcott PA
    J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive molecular profiling broadens treatment options for breast cancer patients.
    Kawaji H; Kubo M; Yamashita N; Yamamoto H; Kai M; Kajihara A; Yamada M; Kurata K; Kaneshiro K; Harada Y; Hayashi S; Shimazaki A; Mori H; Akiyoshi S; Oki E; Oda Y; Baba E; Mori M; Nakamura M
    Cancer Med; 2021 Jan; 10(2):529-539. PubMed ID: 33274848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice.
    Vasan N; Yelensky R; Wang K; Moulder S; Dzimitrowicz H; Avritscher R; Wang B; Wu Y; Cronin MT; Palmer G; Symmans WF; Miller VA; Stephens P; Pusztai L
    Oncologist; 2014 May; 19(5):453-8. PubMed ID: 24710307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of breast cancer tumor genomic testing.
    Damodaran S; Sember QC; Arun BK
    Breast J; 2020 Aug; 26(8):1565-1571. PubMed ID: 32696498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Genomic Testing for Breast Cancer: Utility for Surgeons.
    Fayanju OM; Park KU; Lucci A
    Ann Surg Oncol; 2018 Feb; 25(2):512-519. PubMed ID: 29159748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers.
    Toor OM; Ahmed Z; Bahaj W; Boda U; Cummings LS; McNally ME; Kennedy KF; Pluard TJ; Hussain A; Subramanian J; Masood A
    Mol Cancer Ther; 2018 May; 17(5):1123-1132. PubMed ID: 29500272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating Genomics Into the Care of Patients With Advanced Breast Cancer.
    Kratz J; Burkard M; O'Meara T; Pusztai L; Veitch Z; Bedard PL
    Am Soc Clin Oncol Educ Book; 2018 May; 38():56-64. PubMed ID: 30231387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical target sequencing for precision medicine of breast cancer.
    Tsuchida J; Rothman J; McDonald KA; Nagahashi M; Takabe K; Wakai T
    Int J Clin Oncol; 2019 Feb; 24(2):131-140. PubMed ID: 30604156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.